The invention discloses an innovative human intestinal alpha
defensin 5 (HD5)
receptor P2Y11
screening method, platform and application, and belongs to the field of
biomedicine.The method fuses multiple
omics and experimental strategies, effectively solves the problems that
receptor protein is complex and interaction is difficult to independently identify, remarkably improves the accuracy and reliability of
defensin receptor identification, and has good application prospects. A set of method
system with high universality and wide applicability is provided for receptor research, the first
cell receptor P2Y11 of HD5 is successfully identified by the method, and discovery of the P2Y11 receptor not only opens up a new perspective for deep understanding of biological functions and action mechanisms of HD5, but also provides a new potential target for treatment of related diseases; especially for infectious diseases such as
bacillary dysentery caused by
shigella participated in HD5, a P2Y11 receptor is used as a
drug target, possibility is provided for developing a novel treatment scheme, more
effective treatment choices are expected to be brought to patients, and the
treatment effect and
life quality are remarkably improved.